Hepatic Artery Thrombosis After Orthotopic Liver Transplant: A 20-Year Monocentric Series
Journal of Clinical Medicine · 07.07.2025 · 14 (13) · 4804
DOI: 10.3390/jcm14134804 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Clinical Medicine, online erschienen am 07.07.2025. Verfasst von Vincenzo Tondolo und 7 weiteren Autor:innen. Beteiligte Einrichtung: UOC Chirurgia Digestiva e del Colon-Retto-Ospedale Isola Tiberina Gemelli Isola, 00186 Rome, Italy. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background/Objectives: Hepatic artery thrombosis (HAT) is a serious vascular complication in patients undergoing orthotopic liver transplantation (OLT). It is associated with a high risk of graft loss, re-transplantation (re-OLT), and mortality. This study aimed to evaluate the incidence and management of HAT, analyzing potential risk factors. The secondary objectives included quantifying 90-day postoperative morbidity and mortality rates.
Methods
In this retrospective, observational, single-center study, data from liver transplant donors and recipients who underwent OLT between 2004 and 2024 were analyzed. HAT was classified as early (e-HAT, ≤30 days) or late (l-HAT, >30 days). Univariate statistical analysis was performed to identify the risk factors associated with HAT occurrence. Multivariate analysis was not performed due to the small number of HAT events, which would increase the risk of model overfitting.
Results
In the 20 year study period, a total of 532 OLTs were performed, including 37 re-OLTs. The rates of major morbidity, reoperation, and mortality within 90 days were 44.5%, 22.3%, and 7.1%, respectively. HAT occurred in 2.4% of cases (e-HAT: 1.6%; l-HAT: 0.7%). Among e-HAT cases, 66.6% were asymptomatic and identified through routine postoperative Doppler ultrasound. All e-HAT cases were surgically treated, with a re-OLT rate of 33.3%. Three l-HAT cases required re-OLT. Overall, the HAT-related mortality and re-OLT rates were 7.6% and 46.1%, respectively. At a follow-up of 86 months, the rate of graft loss was 9.2%, and the rate of post-OLT survival was 77%. Patients who developed HAT had a higher donor-to-recipient body weight ratio and longer warm ischemia times (WITs). Additionally, patients undergoing re-OLT had a higher risk of developing HAT.
Conclusions
Although the incidence of HAT is low, its clinical consequences are severe. Early Doppler ultrasound surveillance is crucial for detecting e-HAT and preventing graft loss. A high donor-to-recipient body weight ratio, a prolonged warm ischemia time, and re-OLT seem to be associated with a high risk of HAT.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- UOC Chirurgia Digestiva e del Colon-Retto-Ospedale Isola Tiberina Gemelli Isola, 00186 Rome, Italy.
- Dipartimento di Medicina e Chirurgia Traslazionale, Università Cattolica del Sacro Cuore, 00168 Rome, Italy.
- Centro Trapianti-Azienda Ospedaliera «G. Brotzu», 09047 Cagliari, Italy.
- UOC Chirurgia Digestiva-Fondazione Policlinico Universitario Agostino Gemelli IRCCS, 00168 Rome, Italy.
ORCID-Profile: Vincenzo Tondolo, Gianluca Rizzo, Giovanni Pacini, Federica Marzi
Zitieren
APA
Tondolo, V., Rizzo, G., Pacini, G., Amodio, L. E., Marzi, F., Livadoti, G., Quero, G., & Zamboni, F. (2025). Hepatic Artery Thrombosis After Orthotopic Liver Transplant: A 20-Year Monocentric Series. Journal of Clinical Medicine, 14(13), 4804. https://doi.org/10.3390/jcm14134804
Vancouver
Tondolo V, Rizzo G, Pacini G, Amodio LE, Marzi F, Livadoti G, et al. Hepatic Artery Thrombosis After Orthotopic Liver Transplant: A 20-Year Monocentric Series. Journal of Clinical Medicine. 2025;14(13):4804. doi:10.3390/jcm14134804
BibTeX
@article{Tondolo2025,
author = {Tondolo, Vincenzo and Rizzo, Gianluca and Pacini, Giovanni and Amodio, Luca Emanuele and Marzi, Federica and Livadoti, Giada and Quero, Giuseppe and Zamboni, Fausto},
title = {Hepatic Artery Thrombosis After Orthotopic Liver Transplant: A 20-Year Monocentric Series},
journal = {Journal of Clinical Medicine},
year = {2025},
volume = {14},
number = {13},
pages = {4804},
doi = {10.3390/jcm14134804}
}
EUVIMED